• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NT21(一种假定的产细菌素分离株)的基因组分析

Genomic analysis of NT21, a putative bacteriocin-producing isolate.

作者信息

Tarek Nashwa, El-Gendy Ahmed O, Khairalla Ahmed S, Abdel-Fattah Medhat, Tawfik Eman, Azmy Ahmed F

机构信息

Department of Botany and Microbiology, Faculty of Science, Beni-Suef University, Egypt.

Basic Science Department, Faculty of Oral and Dental medicine, Nahda University Beni-Suef (NUB), Beni.

出版信息

Mol Biol Res Commun. 2022;11(3):143-153. doi: 10.22099/mbrc.2022.44088.1760.

DOI:10.22099/mbrc.2022.44088.1760
PMID:36718242
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9661671/
Abstract

species are a long-standing and non-pathogenic commensal bacterium, representing an important part of the normal. is a rarely isolated species from animals and humans, and it was a tiny constituent of human oral cavity and animal intestinal flora, as well as animal-derived foods, particularly dairy products. This study evaluated the security of our strain NT21 by using whole-genome sequencing (WGS), physicochemical features, and antimicrobial activity. The complete genomic of our strain NT21was sequenced and analyzed by using several bioinformatics tools to identify bacteriocin genes, virulence genes, antibiotic resistance genes, Crispr-Cas and pathogenicity islands. The results showed that our strain NT21 lacks the presence of virulence genes, pathogenicity islands, plasmids and has only two antibiotic resistance genes. On the other hand, it produces three bacteriocin-like inhibitory substances (Enterolysin A, P and L50a). It has six gene-encoded Crisper-Cas and one cluster Crispr-Cas gene. According to our findings, NT21 is a possible probiotic strain that is safe for both human and animal use.

摘要

[物种名称]是一种长期存在的非致病性共生细菌,是正常菌群的重要组成部分。它是一种很少从动物和人类中分离出来的物种,是人类口腔、动物肠道菌群以及动物源性食品(特别是乳制品)中的微量成分。本研究通过全基因组测序(WGS)、理化特性和抗菌活性评估了我们的NT21菌株的安全性。使用多种生物信息学工具对我们的NT21菌株的完整基因组进行测序和分析,以鉴定细菌素基因、毒力基因、抗生素抗性基因、CRISPR-Cas和致病岛。结果表明,我们的NT21菌株不存在毒力基因、致病岛、质粒,并且只有两个抗生素抗性基因。另一方面,它产生三种类细菌素抑制物质(肠溶素A、P和L50a)。它有六个基因编码的CRISPR-Cas和一个成簇的CRISPR-Cas基因。根据我们的研究结果,NT21是一种对人和动物使用都安全的潜在益生菌菌株。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce69/9661671/189db4bd660e/mbrc-11-143-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce69/9661671/33c6fe90a893/mbrc-11-143-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce69/9661671/2f3722af6c71/mbrc-11-143-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce69/9661671/bfe49bf58705/mbrc-11-143-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce69/9661671/189db4bd660e/mbrc-11-143-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce69/9661671/33c6fe90a893/mbrc-11-143-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce69/9661671/2f3722af6c71/mbrc-11-143-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce69/9661671/bfe49bf58705/mbrc-11-143-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce69/9661671/189db4bd660e/mbrc-11-143-g004.jpg

相似文献

1
Genomic analysis of NT21, a putative bacteriocin-producing isolate.NT21(一种假定的产细菌素分离株)的基因组分析
Mol Biol Res Commun. 2022;11(3):143-153. doi: 10.22099/mbrc.2022.44088.1760.
2
Genome sequence and probiotic potential of newly isolated Enterococcus durans strain MN187066.新分离的屎肠球菌 MN187066 株的基因组序列和益生菌潜力。
Lett Appl Microbiol. 2023 Mar 1;76(3). doi: 10.1093/lambio/ovad035.
3
Genome sequencing of NT04, an oral microbiota revealed the production of enterocin A/B active against oral pathogens.对一种口腔微生物群NT04进行的全基因组测序显示,它能产生对口腔病原体具有活性的肠球菌素A/B。
Heliyon. 2023 May 24;9(6):e16253. doi: 10.1016/j.heliyon.2023.e16253. eCollection 2023 Jun.
4
Assessment of Safety and Probiotic Traits of OSY-EGY, Isolated From Egyptian Artisanal Cheese, Using Comparative Genomics and Phenotypic Analyses.使用比较基因组学和表型分析评估从埃及手工奶酪中分离出的OSY-EGY的安全性和益生菌特性
Front Microbiol. 2020 Dec 11;11:608314. doi: 10.3389/fmicb.2020.608314. eCollection 2020.
5
Complete genome sequence of KLDS6.0933, a potential probiotic strain with high cholesterol removal ability.具有高胆固醇去除能力的潜在益生菌菌株KLDS6.0933的全基因组序列
Gut Pathog. 2018 Jul 19;10:32. doi: 10.1186/s13099-018-0260-y. eCollection 2018.
6
Genomic analysis of Enterococcus durans LAB18S, a potential probiotic strain isolated from cheese.耐久肠球菌LAB18S的基因组分析,LAB18S是一种从奶酪中分离出的潜在益生菌菌株。
Genet Mol Biol. 2022 Feb 25;45(1):e20210201. doi: 10.1590/1678-4685-GMB-2021-0201. eCollection 2022.
7
Evaluating the Safety of Potential Probiotic KLDS6.0930 Using Whole Genome Sequencing and Oral Toxicity Study.利用全基因组测序和口服毒性研究评估潜在益生菌KLDS6.0930的安全性。
Front Microbiol. 2018 Aug 21;9:1943. doi: 10.3389/fmicb.2018.01943. eCollection 2018.
8
High inhibition of Paenibacillus larvae and Listeria monocytogenes by Enterococcus isolated from different sources in Tunisia and identification of their bacteriocin genes.突尼斯不同来源分离出的肠球菌对幼虫芽孢杆菌和单核细胞增生李斯特菌具有高度抑制作用及其细菌素基因的鉴定
Lett Appl Microbiol. 2014 Jul;59(1):17-25. doi: 10.1111/lam.12239. Epub 2014 Mar 20.
9
Complete genome sequence of Enterococcus durans KLDS6.0930, a strain with probiotic properties.具有益生菌特性的耐久肠球菌KLDS6.0930的全基因组序列
J Biotechnol. 2016 Jan 10;217:49-50. doi: 10.1016/j.jbiotec.2015.11.012. Epub 2015 Nov 23.
10
Genomic-based characterization of Enterococcus spp.: an emerging pathogen isolated from human gut.基于基因组的肠球菌属特征分析:一种从人类肠道中分离出的新兴病原体。
Mol Biol Rep. 2021 Jun;48(6):5371-5376. doi: 10.1007/s11033-021-06540-5. Epub 2021 Jul 7.

引用本文的文献

1
Seasonal prevalence and antimicrobial resistance profiles in spp. identified from mussels farmed along the coasts of the Abruzzo region.从亚得里亚海沿岸养殖贻贝中鉴定出的 物种的季节性流行情况和抗菌药物耐药性概况。 需注意,原文中“ spp.”表述不完整,可能影响更准确理解和翻译,这里按现有内容尽量准确翻译了。
Ital J Food Saf. 2025 Aug 6;14(3). doi: 10.4081/ijfs.2025.13563. Epub 2025 Apr 2.
2
CRISPR-Cas systems in enterococci.肠球菌中的CRISPR-Cas系统。
Braz J Microbiol. 2024 Dec;55(4):3945-3957. doi: 10.1007/s42770-024-01549-x. Epub 2024 Oct 23.

本文引用的文献

1
Special Issue "Enterococci for Probiotic Use: Safety and Risk": Editorial.特刊“用于益生菌的肠球菌:安全性与风险”:编者按
Microorganisms. 2022 Mar 12;10(3):604. doi: 10.3390/microorganisms10030604.
2
Genomic analysis of Enterococcus durans LAB18S, a potential probiotic strain isolated from cheese.耐久肠球菌LAB18S的基因组分析,LAB18S是一种从奶酪中分离出的潜在益生菌菌株。
Genet Mol Biol. 2022 Feb 25;45(1):e20210201. doi: 10.1590/1678-4685-GMB-2021-0201. eCollection 2022.
3
Probiotic Potential Analysis and Safety Evaluation of A8-1 Isolated From a Healthy Chinese Infant.
从一名健康中国婴儿分离出的A8-1的益生菌潜力分析与安全性评估
Front Microbiol. 2021 Dec 14;12:799173. doi: 10.3389/fmicb.2021.799173. eCollection 2021.
4
Probiotic potential and safety assessment of bacteriocinogenic strains with antibacterial activity against and vancomycin-resistant enterococci.对具有抗万古霉素耐药肠球菌抗菌活性的产细菌素菌株的益生菌潜力及安全性评估
Curr Res Microb Sci. 2021 Aug 30;2:100070. doi: 10.1016/j.crmicr.2021.100070. eCollection 2021 Dec.
5
Bacteriocin producing microbes with bactericidal activity against multidrug resistant pathogens.具有杀菌活性的抗菌肽产生微生物,可对抗多种耐药病原体。
J Infect Public Health. 2021 Dec;14(12):1802-1809. doi: 10.1016/j.jiph.2021.09.029. Epub 2021 Oct 5.
6
Potential Probiotic OV3-6 and Its Bioactive Peptide as Alternative Bio-Preservation.潜在益生菌OV3-6及其生物活性肽作为替代生物防腐剂
Foods. 2021 Sep 24;10(10):2264. doi: 10.3390/foods10102264.
7
spp. as a Producer and Target of Bacteriocins: A Double-Edged Sword in the Antimicrobial Resistance Crisis Context.作为细菌素的生产者和靶标的物种:抗菌药物耐药性危机背景下的双刃剑
Antibiotics (Basel). 2021 Oct 7;10(10):1215. doi: 10.3390/antibiotics10101215.
8
Assessment of Safety and Probiotic Traits of OSY-EGY, Isolated From Egyptian Artisanal Cheese, Using Comparative Genomics and Phenotypic Analyses.使用比较基因组学和表型分析评估从埃及手工奶酪中分离出的OSY-EGY的安全性和益生菌特性
Front Microbiol. 2020 Dec 11;11:608314. doi: 10.3389/fmicb.2020.608314. eCollection 2020.
9
Dietary Amino Acids and the Gut-Microbiome-Immune Axis: Physiological Metabolism and Therapeutic Prospects.膳食氨基酸与肠道微生物群-免疫轴:生理代谢与治疗前景
Compr Rev Food Sci Food Saf. 2019 Jan;18(1):221-242. doi: 10.1111/1541-4337.12401. Epub 2018 Dec 18.
10
How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance.CRISPR-Cas系统如何用于对抗抗菌药物耐药性。
Infect Drug Resist. 2020 Apr 20;13:1111-1121. doi: 10.2147/IDR.S247271. eCollection 2020.